This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Data availability
All data generated or analyzed during this study are included in this published article and its supplementary information files.
References
Li Z, Wang L, Wu X, Jiang J, Qiang W, Xie H, et al. Artificial intelligence in ophthalmology: the path to the real-world clinic. Cell Rep Med. 2023;4:101095.
Mihalache A, Huang RS, Popovic MM, Muni RH. ChatGPT-4: an assessment of an upgraded artificial intelligence chatbot in the United States Medical Licensing Examination. Med Teach. 2023: 1–7. Available at: https://www.tandfonline.com/doi/full/10.1080/0142159X.2023.2249588.
Kung TH, Cheatham M, Medenilla A, Sillos C, De Leon L, Elepaño C, et al. Performance of ChatGPT on USMLE: potential for AI-assisted medical education using large language models Dagan A (ed). PLoS Digit Health. 2023;2:e0000198 https://dx.plos.org/10.1371/journal.pdig.0000198.
Mihalache A, Huang RS, Popovic MM, Patil NS, Shor R, Pandya BU, et al. Accuracy of an artificial intelligence chatbot’s interpretation of clinical ophthalmic images. JAMA Ophthalmol. https://doi.org/10.1001/jamaophthalmol.2024.0017.
Mihalache A, Popovic MM, Muni RH. Performance of an artificial intelligence chatbot in ophthalmic knowledge assessment. JAMA Ophthalmol. 2023;141:589–97.
Mihalache A, Huang RS, Popovic MM, Muni RH. Performance of an upgraded artificial intelligence chatbot for ophthalmic knowledge assessment. JAMA Ophthalmol. 2023;141:798–800.
Kawali A, Pichi F, Avadhani K, Invernizzi A, Hashimoto Y, Mahendradas P. Multimodal imaging of the normal eye. Ocul Immunol Inflamm. 2017;25:726–36.
Dave T, Athaluri SA, Singh S. ChatGPT in medicine: an overview of its applications, advantages, limitations, future prospects, and ethical considerations. Front Artif Intell. 2023;6:1169595.
OpenAI. GPT-4V(ision) system card. OpenAI. 2023. Available at: https://openai.com/research/gpt-4v-system-card Accessed 7 Jan 2024.
Anton N, Doroftei B, Curteanu S, Catãlin L, Ilie OD, Târcoveanu F, et al. Comprehensive review on the use of artificial intelligence in ophthalmology and future research directions. Diagnostics. 2023;13:100.
Acknowledgements
RHM’s research is supported by the Silber TARGET Fund. AP is the cofounder of OCTCases, and AM and BUP are involved in the operation of the OCTCases website. Information reported in this manuscript has not been previously presented at a conference. Data was collected from the artificial intelligence chatbot ChatGPT-4 developed by OpenAI.
Funding
Silber TARGET Fund.
Author information
Authors and Affiliations
Contributions
AM was responsible for the conception of the study, reviewing the chatbot’s responses, analyzing data, interpreting results, and writing the manuscript. RSH was responsible for prompting the chatbot, reviewing the chatbot’s responses, and extracting data. MCP was responsible for reviewing the chatbot’s responses and revision of the manuscript. NSP was responsible for revision of the manuscript. MMP was responsible for the conception of the study and revision of the manuscript. BUP was responsible for revision of the manuscript. RS was responsible for revision of the manuscript. AP was responsible for supervision of the study and revision of the manuscript. RHM was responsible for supervision of the study and revision of the manuscript.
Corresponding author
Ethics declarations
Competing interests
AM: None; RSH: None; MCP: None; NSP: None; MMP: Financial support (to institution) – PSI Foundation, Fighting Blindness Canada; BUP: None; RS: None; AP: None; RHM: Consultant - Alcon, Apellis, AbbVie, Bayer, Bausch Health, Roche; Financial Support (to institution)- Alcon, AbbVie, Bayer, Novartis, Roche.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
41433_2024_3074_MOESM3_ESM.pdf
eFigure 2. Example response from the chatbot (left) compared to a model answer from OCTCases (right) for an open-ended question answered fully correctly.
41433_2024_3074_MOESM4_ESM.pdf
eFigure 3. Example response from the chatbot (left) compared to a model answer from OCTCases (right) for an open-ended question answered partially correctly.
41433_2024_3074_MOESM5_ESM.pdf
eFigure 4. Example response from the chatbot (left) compared to a model answer from OCTCases (right) for an open-ended question answered fully incorrectly.  
Rights and permissions
About this article
Cite this article
Mihalache, A., Huang, R.S., Cruz-Pimentel, M. et al. Artificial intelligence chatbot interpretation of ophthalmic multimodal imaging cases. Eye (2024). https://doi.org/10.1038/s41433-024-03074-5
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41433-024-03074-5